JANX

Janux Therapeutics (JANX)

About Janux Therapeutics (JANX)

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$62.30
52 Week Low
$14.85
Market cap
909.4M
Dividend yield
0.00%
Volume
--
Avg. volume
2.7M
P/E ratio
-9.03

Janux Therapeutics News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$62.30
52 Week Low
$14.85
Market cap
909.4M
Dividend yield
0.00%
Volume
--
Avg. volume
2.7M
P/E ratio
-9.03